On 1 October 2025 in Washington, D.C., IFPMA and FIFARMA delivered a statement on Agenda Item 4.5 Plan of Action on Noncommunicable Disease Prevention and Control 2025–2030 during the 77th Session of the Regional Committee of WHO for the Americas. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Latin American Federation of...
Read moreUN HLM on NCDs and Mental Health: Joint statement on the importance of embedding life-course immunization and integrated multimorbidity approaches in NCD prevention and care On the occasion of the UN General Assembly’s Fourth High-Level Meeting on NCDs and Mental Health, the International Federation on Ageing (IFA), the Global Allergy & Airways Patient Platform (GAAPP),...
Read moreOn 25 September 2025, IFPMA delivered a statement at the UN High-Level Meeting on NCDs and Mental Health in New York.
Read more